Healthcare provider profile · identity verified

Christopher Michael Broadway, M.D.

Family Practice · WAXAHACHIE, TX · NPI 1639308836

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	599	167
Amlodipine Besylate	Amlodipine Besylate	481	139
Lisinopril	Lisinopril	443	126
Levothyroxine Sodium	Levothyroxine Sodium	385	97
Losartan Potassium	Losartan Potassium	367	101
Rosuvastatin Calcium	Rosuvastatin Calcium	300	90
Gabapentin	Gabapentin	270	74
Meloxicam	Meloxicam	263	81
Metformin Hcl Er	Metformin Hcl	249	67
Trazodone Hcl	Trazodone Hcl	236	73
Fluticasone Propionate	Fluticasone Propionate	224	103
Simvastatin	Simvastatin	224	61
Pravastatin Sodium	Pravastatin Sodium	209	51
Pantoprazole Sodium	Pantoprazole Sodium	205	67
Albuterol Sulfate Hfa	Albuterol Sulfate	202	69
Metformin Hcl	Metformin Hcl	202	55
Omeprazole	Omeprazole	202	61
Tamsulosin Hcl	Tamsulosin Hcl	202	58
Hydrochlorothiazide	Hydrochlorothiazide	184	53
Metoprolol Succinate	Metoprolol Succinate	169	50
Jardiance	Empagliflozin	160	36
Citalopram Hbr	Citalopram Hydrobromide	152	41
Glimepiride	Glimepiride	147	42
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	144	49
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	140	36
Carvedilol	Carvedilol	137	44
Ozempic	Semaglutide	134	28
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	131	39
Montelukast Sodium	Montelukast Sodium	125	36
Eliquis	Apixaban	124	21
Furosemide	Furosemide	116	38
Tramadol Hcl	Tramadol Hcl	116	17
Metoprolol Tartrate	Metoprolol Tartrate	114	30
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	113	30
Finasteride	Finasteride	107	27
Celecoxib	Celecoxib	92	28
Famotidine	Famotidine	91	25
Methocarbamol	Methocarbamol	91	38
Buspirone Hcl	Buspirone Hcl	89	14
Escitalopram Oxalate	Escitalopram Oxalate	87	22
Allopurinol	Allopurinol	86	24
Lovastatin	Lovastatin	82	22
Pregabalin	Pregabalin	80	29
Sertraline Hcl	Sertraline Hcl	76	18
Clopidogrel	Clopidogrel Bisulfate	66	19
Paroxetine Hcl	Paroxetine Hcl	64	15
Zolpidem Tartrate	Zolpidem Tartrate	64	suppressed
Glipizide	Glipizide	63	19
Methylprednisolone	Methylprednisolone	63	52
Pioglitazone Hcl	Pioglitazone Hcl	62	19
Januvia	Sitagliptin Phosphate	61	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	61	11
Amitriptyline Hcl	Amitriptyline Hcl	60	14
Ezetimibe	Ezetimibe	58	16
Doxycycline Hyclate	Doxycycline Hyclate	57	48
Valsartan	Valsartan	51	15
Trulicity	Dulaglutide	50	suppressed
Meclizine Hcl	Meclizine Hcl	49	21
Benazepril Hcl	Benazepril Hcl	48	14
Azelastine Hcl	Azelastine Hcl	46	17
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	46	11
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	46	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	45	18
Fluoxetine Hcl	Fluoxetine Hcl	44	13
Potassium Chloride	Potassium Chloride	44	13
Duloxetine Hcl	Duloxetine Hcl	43	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	43	13
Amoxicillin	Amoxicillin	42	36
Spironolactone	Spironolactone	42	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	40	13
Nifedipine Er	Nifedipine	39	13
Triamcinolone Acetonide	Triamcinolone Acetonide	39	34
Alendronate Sodium	Alendronate Sodium	38	suppressed
Hydralazine Hcl	Hydralazine Hcl	36	11
Naproxen	Naproxen	36	14
Oxybutynin Chloride	Oxybutynin Chloride	36	15
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	35	suppressed
Farxiga	Dapagliflozin Propanediol	34	suppressed
Linzess	Linaclotide	33	11
Ropinirole Hcl	Ropinirole Hcl	33	suppressed
Solifenacin Succinate	Solifenacin Succinate	33	suppressed
Synthroid	Levothyroxine Sodium	33	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	32	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	32	12
Enalapril Maleate	Enalapril Maleate	32	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	32	11
Ciclopirox	Ciclopirox	31	11
Mounjaro	Tirzepatide	31	suppressed
Bupropion Xl	Bupropion Hcl	30	suppressed
Cefdinir	Cefdinir	30	27
Ketoconazole	Ketoconazole	30	17
Azithromycin	Azithromycin	29	27
Dicyclomine Hcl	Dicyclomine Hcl	29	suppressed
Mirtazapine	Mirtazapine	29	suppressed
Prednisone	Prednisone	29	22
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	27	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	27	suppressed
Glipizide Er	Glipizide	27	suppressed
Ibandronate Sodium	Ibandronate Sodium	27	13
Ramipril	Ramipril	27	suppressed
Atenolol	Atenolol	26	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	26	suppressed
Nebivolol Hcl	Nebivolol Hcl	26	suppressed
Cephalexin	Cephalexin	24	23
Diclofenac Sodium	Diclofenac Sodium	24	13
Tresiba Flextouch U-100	Insulin Degludec	24	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	24	suppressed
Xarelto	Rivaroxaban	24	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	23	suppressed
Irbesartan	Irbesartan	23	suppressed
Nystatin	Nystatin	23	suppressed
Propranolol Hcl	Propranolol Hcl	23	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Clonidine Hcl	Clonidine Hcl	22	suppressed
Ibuprofen	Ibuprofen	22	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	22	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	21	19
Donepezil Hcl	Donepezil Hcl	21	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	20	18
Doxazosin Mesylate	Doxazosin Mesylate	20	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	20	suppressed
Humalog Kwikpen U-100	Insulin Lispro	19	suppressed
Megestrol Acetate	Megestrol Acetate	19	suppressed
Spiriva Respimat	Tiotropium Bromide	19	suppressed
Aripiprazole	Aripiprazole	18	suppressed
Breo Ellipta	Fluticasone/Vilanterol	18	suppressed
Gemfibrozil	Gemfibrozil	18	suppressed
Tradjenta	Linagliptin	18	suppressed
Warfarin Sodium	Warfarin Sodium	18	suppressed
Novolog Flexpen	Insulin Aspart	17	suppressed
Sucralfate	Sucralfate	17	suppressed
Tizanidine Hcl	Tizanidine Hcl	17	suppressed
Acyclovir	Acyclovir	16	suppressed
Alprazolam	Alprazolam	16	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	16	suppressed
Eszopiclone	Eszopiclone	16	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Terazosin Hcl	Terazosin Hcl	16	suppressed
Hydrocortisone	Hydrocortisone	15	12
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	13
Rybelsus	Semaglutide	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	11
Xulane	Norelgestromin/Ethin.Estradiol	15	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	14	suppressed
Creon	Lipase/Protease/Amylase	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Ondansetron Odt	Ondansetron	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Topiramate	Topiramate	14	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Entresto	Sacubitril/Valsartan	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Clonazepam	Clonazepam	12	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	12	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Cyproheptadine Hcl	Cyproheptadine Hcl	11	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error